XML 77 R42.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]  
Summary of stock options valuation assumptions
The assumptions used to estimate the fair values of the share options granted are as follows:
 
    
For the years ended December 31,
    
2022
 
2023
 
2024
Risk-free interest rate
  
1.52%-3.94%
 
3.48%-4.61%
 
3.70%-4.57%
Dividend yield
   0%   0%   0%
Expected volatility range
  
48.20%-56.00%
 
47.9%-50.69%
 
47.83%-52.04%
Exercise multiple
   2.8   N/A   N/A
Contractual life
   10 years   10 years   10 years
Fair market value per ordinary share as at valuation dates
  
US$0.013-9.29
 
US$0.93-3.11
 
US$0.28-0.76
Summary of share options activity
The following table summarizes the share option activities for the year ended December 31, 2024:
 
    
Number of

options
   
Weighted-

average

exercise

price
    
Weighted-

average

grant

date

fair value
    
Weighted

average

remaining

contractual

term
    
Aggregate

intrinsic

value
 
          
US$ per
option
    
US$ per
option
    
Years
    
US$
 
Outstanding, January 1, 2024
  
 
21,005,541
 
 
 
1.7560
 
  
 
7.84
 
  
 
5.61
 
  
 
10,441
 
  
 
 
            
Granted
     1,395,408       0.0002        0.74        
Exercised
     (5,173,523     0.0002        24.30        
Forfeited
     (2,287,481     1.5826        1.59        
  
 
 
            
Outstanding, December 31, 2024
  
 
14,939,945
 
 
 
2.2266
 
  
 
2.43
 
  
 
7.72
 
  
 
4,238
 
  
 
 
            
Vested and expected to vest at December 31, 2024
  
 
14,939,945
 
 
 
2.2266
 
  
 
2.43
 
  
 
7.72
 
  
 
4,238
 
  
 
 
            
Exercisable at December 31, 2024
  
 
1,251,990
 
 
 
2.9451
 
  
 
16.82
 
  
 
5.05
 
  
 
901
 
  
 
 
            
Summary of restricted shares activities The following table summarizes the restricted shares unit activities for the year ended December 31, 2024:
 
    
Number of

shares
    
Weighted-

average

grant

date

fair value
    
Weighted

average

remaining

contractual

term
    
Aggregate
intrinsic
value
 
           
US$ per
unit
    
Years
    
US$
 
Outstanding, December 31, 2023
     31,330        2.43        8.72        33  
  
 
 
          
Vested
     (31,330      2.43        
  
 
 
          
Outstanding, December 31, 2024
     —         —         —         —   
  
 
 
          
Vested and expected to vest at December 31, 2024
     25,267        2.34        7.47        19  
  
 
 
          
Summary of share-based compensation expenses
Total share-based compensation expenses recognized for the years ended December 31, 2022, 2023 and 2024 were as follows:
 
    
For the years ended December 31,
 
    
2022
    
2023
    
2024
 
    
RMB
    
RMB
    
RMB
    
US$
 
Cost of revenues
     1,783        2,313        1,869        256  
Research and development expenses
     52,873        53,474        30,677        4,203  
Selling and marketing expenses
     8,525        9,658        5,010        686  
General and administrative expenses
     263,603        195,274        118,066        16,175  
  
 
 
    
 
 
    
 
 
    
 
 
 
  
 
326,784
 
  
 
260,719
 
  
 
155,622
 
  
 
21,320